NCT00544362 - Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

March 31, 2013

Conditions

Esophageal Cancer

Interventions

BIOLOGICAL

cetuximab

DRUG

cisplatin

DRUG

fluorouracil

PROCEDURE

conventional surgery

Trial Locations (13)

13385

CHU de la Timone, Marseille

21034

Hopital Du Bocage, Dijon

21079

Federation Francophone de Cancerologie Digestive, Dijon

25030

Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz, Besançon

29200

C.H.U. de Brest, Brest

31059

Centre Hospitalier Regional de Purpan, Toulouse

33075

Hopital Saint Andre, Bordeaux

34298

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier

54511

Centre Alexis Vautrin, Vandœuvre-lès-Nancy

59020

Centre Oscar Lambret, Lille

59037

Centre Hospital Universitaire Hop Huriez, Lille

63058

CHR Clermont Ferrand, Hotel Dieu, Clermont-Ferrand

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

All Listed Sponsors

lead

Federation Francophone de Cancerologie Digestive

OTHER